EP1144640A3 - Nukleinsaüren und entsprechende proteine aus streptococcus pneumoniae - Google Patents

Nukleinsaüren und entsprechende proteine aus streptococcus pneumoniae

Info

Publication number
EP1144640A3
EP1144640A3 EP99934990A EP99934990A EP1144640A3 EP 1144640 A3 EP1144640 A3 EP 1144640A3 EP 99934990 A EP99934990 A EP 99934990A EP 99934990 A EP99934990 A EP 99934990A EP 1144640 A3 EP1144640 A3 EP 1144640A3
Authority
EP
European Patent Office
Prior art keywords
proteins
nucleic acids
streptococcus pneumoniae
pneumoniae
streptococcus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99934990A
Other languages
English (en)
French (fr)
Other versions
EP1144640A2 (de
Inventor
Richard William Falla Le Page
Jeremy Mark Actinova Ltd. WELLS
Sean Bosco Hanniffy
Philip Michael CBVT Dis. Immun.Microbio HANSBRO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Technics Ltd
Original Assignee
Microbial Technics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9816336.3A external-priority patent/GB9816336D0/en
Application filed by Microbial Technics Ltd filed Critical Microbial Technics Ltd
Priority to EP05019268A priority Critical patent/EP1624064A3/de
Priority to EP07000680A priority patent/EP1801218A3/de
Publication of EP1144640A2 publication Critical patent/EP1144640A2/de
Publication of EP1144640A3 publication Critical patent/EP1144640A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP99934990A 1998-07-27 1999-07-27 Nukleinsaüren und entsprechende proteine aus streptococcus pneumoniae Withdrawn EP1144640A3 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP05019268A EP1624064A3 (de) 1998-07-27 1999-07-27 Nukleinsäuren und entsprechende Proteine aus streptococcus pneumoniae
EP07000680A EP1801218A3 (de) 1998-07-27 1999-07-27 Nukleinsäuren und Proteine aus Pneumokokken

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9816336.3A GB9816336D0 (en) 1998-07-27 1998-07-27 Proteins
GB9816336 1998-07-27
US12532999P 1999-03-19 1999-03-19
US125329P 1999-03-19
PCT/GB1999/002452 WO2000006738A2 (en) 1998-07-27 1999-07-27 NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP05019268A Division EP1624064A3 (de) 1998-07-27 1999-07-27 Nukleinsäuren und entsprechende Proteine aus streptococcus pneumoniae

Publications (2)

Publication Number Publication Date
EP1144640A2 EP1144640A2 (de) 2001-10-17
EP1144640A3 true EP1144640A3 (de) 2001-11-28

Family

ID=26314124

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99934990A Withdrawn EP1144640A3 (de) 1998-07-27 1999-07-27 Nukleinsaüren und entsprechende proteine aus streptococcus pneumoniae

Country Status (4)

Country Link
EP (1) EP1144640A3 (de)
JP (2) JP2002521058A (de)
CN (1) CN1318103A (de)
WO (1) WO2000006738A2 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
ES2512496T3 (es) 1998-07-22 2014-10-24 Stichting Dienst Landbouwkundig Onderzoek Vacunas y pruebas de diagnóstico de Streptococcus suis
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
EP1950302B1 (de) * 1998-12-23 2012-12-05 ID Biomedical Corporation of Quebec Streptokokken-Antigene
TR200200633T2 (tr) * 1998-12-23 2002-06-21 Shire Biochem Inc. Yeni streptococcus antijenleri
US6887480B1 (en) 1999-06-10 2005-05-03 Medimmune, Inc. Streptococcus pneumoniae proteins and vaccines
AU777856B2 (en) * 1999-06-10 2004-11-04 Human Genome Sciences, Inc. Streptococcus pneumoniae proteins and vaccines
DE10012370A1 (de) * 2000-03-14 2001-09-27 Chiron Behring Gmbh & Co Adjuvans für Vakzinen
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
EP1205552A1 (de) * 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Streptokokkenvirulenz mit ORF aus Streptococcus suis
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
GB0107658D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
GB0108079D0 (en) * 2001-03-30 2001-05-23 Microbial Technics Ltd Protein
US7262024B2 (en) 2001-12-20 2007-08-28 Id Biomedical Corporation Streptococcus antigens
AU2003286056A1 (en) * 2002-11-26 2004-06-18 Id Biomedical Corporation Streptococcus pneumoniae surface polypeptides
EP2311989A1 (de) * 2003-04-15 2011-04-20 Intercell AG S. pneumoniae Antigene
CN101155833B (zh) * 2005-04-08 2011-04-20 惠氏公司 通过pH操作将污染物与肺炎链球菌多糖分离
GB0714963D0 (en) * 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
MY150481A (en) 2008-03-03 2014-01-30 Irm Llc Compounds and compositions as tlr activity modulators
US8241643B2 (en) 2008-03-17 2012-08-14 Intercell Ag Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto
ATE523204T1 (de) 2009-02-16 2011-09-15 Karlsruher Inst Technologie Cd44v6-peptide als bakterielle infektionsinhibitoren
US9517263B2 (en) 2009-06-10 2016-12-13 Glaxosmithkline Biologicals Sa Benzonaphthyridine-containing vaccines
KR101748453B1 (ko) 2009-06-29 2017-06-16 제노시아 바이오사이언스, 인크. 폐렴구균(Ｓｔｒｅｐｔｏｃｏｃｃｕｓ Ｐｎｅｕｍｏｎｉａｅ)에 대항하는 백신과 조성물
TWI445708B (zh) 2009-09-02 2014-07-21 Irm Llc 作為ｔｌｒ活性調節劑之化合物及組合物
ES2443952T3 (es) 2009-09-02 2014-02-21 Novartis Ag Composiciones inmunógenas que incluyen moduladores de la actividad de TLR
EP2475385A1 (de) 2009-09-10 2012-07-18 Novartis AG Kombinationsimpfstoffe gegen atemwegserkrankungen
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
SG181712A1 (en) 2009-12-15 2012-07-30 Novartis Ag Homogeneous suspension of immunopotentiating compounds and uses thereof
US20130039947A1 (en) 2010-03-12 2013-02-14 Children's Medical Center Corporation Novel immunogens and methods for discovery and screening thereof
CA2792938C (en) 2010-03-23 2018-07-31 Irm Llc Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
WO2012072769A1 (en) 2010-12-01 2012-06-07 Novartis Ag Pneumococcal rrgb epitopes and clade combinations
JP6126993B2 (ja) 2011-01-20 2017-05-10 ジェノセア バイオサイエンシーズ， インコーポレイテッド 肺炎連鎖球菌（Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ）に対するワクチン及び組成物
US20150132339A1 (en) 2012-03-07 2015-05-14 Novartis Ag Adjuvanted formulations of streptococcus pneumoniae antigens
CN105188747A (zh) 2013-02-01 2015-12-23 葛兰素史密斯克莱生物公司 包含toll样受体激动剂的免疫组合物的皮内递送
ES2959258T3 (es) * 2013-02-07 2024-02-22 Childrens Medical Center Antígenos proteicos que proporcionan protección contra la colonización y/o la enfermedad neumocócicas
CN103834667B (zh) * 2013-12-31 2016-08-17 李越希 化学合成的肺炎链球菌PspA蛋白胞外区基因片段及其表达、应用
BR112020016314A2 (pt) 2018-02-12 2020-12-15 Inimmune Corporation Compostos ou um sais farmaceuticamente aceitáveis, composição farmacêutica, kit, e, métodos para elicitar, intensificar ou modificar uma resposta imunológica, para tratar, prevenir ou reduzir a suscetibilidade a câncer, para tratar, prevenir ou reduzir a suscetibilidade a uma doença infecciosa, para tratar, prevenir ou reduzir a suscetibilidade a uma alergia, para tratar, prevenir ou reduzir a suscetibilidade a uma afecção autoimune, para tratar, prevenir ou reduzir a suscetibilidade em um sujeito à infecção bacteriana, viral, priônica, autoimunidade, câncer ou alergia, para tratar, prevenir ou reduzir a suscetibilidade à autoimunidade, alergia, reperfusão de isquemia ou sepse, para tratar, prevenir ou reduzir a gravidade de ataques epiléticos e para tratar, prevenir ou reduzir a suscetibilidade a doenças oculares como degeneração macular, hipertensão ocular e infecção ocular
WO2020056202A1 (en) 2018-09-12 2020-03-19 Affinivax, Inc. Multivalent pneumococcal vaccines
SG11202101973YA (en) * 2018-09-12 2021-03-30 Childrens Medical Ct Corp Pneumococcal fusion protein vaccines
CA3198876A1 (en) 2020-11-04 2022-05-12 Eligo Bioscience Cutibacterium acnes recombinant phages, method of production and uses thereof
CA3231684A1 (en) 2021-09-09 2023-03-16 Affinivax, Inc. Multivalent pneumococcal vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
EP0907738A1 (de) * 1996-04-02 1999-04-14 Smithkline Beecham Corporation Neue verbindungen
US6294661B1 (en) * 1996-05-14 2001-09-25 Smithkline Beecham Corporation Compounds
DE69737125T3 (de) * 1996-10-31 2015-02-26 Human Genome Sciences, Inc. Streptococcus pneumoniae-Antigene und Impfstoffe
US6074847A (en) * 1996-12-13 2000-06-13 Eli Lilly And Company Streptococcus pneumoniae gene sequence HI1146
GB9700939D0 (en) * 1997-01-17 1997-03-05 Microbial Technics Limited Therapy

Also Published As

Publication number Publication date
WO2000006738A3 (en) 2001-08-23
JP2008022856A (ja) 2008-02-07
JP2002521058A (ja) 2002-07-16
EP1144640A2 (de) 2001-10-17
CN1318103A (zh) 2001-10-17
WO2000006738A2 (en) 2000-02-10

Similar Documents

Publication Publication Date Title
EP1144640A3 (de) Nukleinsaüren und entsprechende proteine aus streptococcus pneumoniae
AU2002309130A1 (en) Streptococcus pneumoniae proteins and nucleic acids
AU2002214127A1 (en) Nucleic acids and proteins from streptococcus groups A and B
AU5793798A (en) Streptococcus pneumoniae dna sequences
WO1999046281A8 (en) Novel polypeptides and nucleic acids encoding the same
AU2002214531A1 (en) Proteins and nucleic acids encoding same
AU6667998A (en) Nucleic acids encoding caspase-8h and caspase-8i
AU2486300A (en) Secreted proteins and nucleic acids encoding them
AU2001288390A1 (en) Proteins and nucleic acids encoding same
AU6280899A (en) Secreted proteins and nucleic acids encoding them
AU2710400A (en) Monocyte-derived nucleic acids and related compositions and methods
AU3511100A (en) Novel nucleic acids and polypeptides
AU6164099A (en) Hrpca 9 and hrpca 10 nucleic acids and polypeptides
AU1525499A (en) Ikap proteins, nucleic acids and methods
AU5377599A (en) Nucleic acids
AU2002211681A1 (en) Proteins and nucleic acids encoding same
AU7756100A (en) Interleukin-2 like protein and nucleic acids encoding same
AU2002227445A1 (en) Proteins and nucleic acids encoding same
AU1690200A (en) Novel protein and dna thereof
AU2059500A (en) Huhdgfh nucleic acids, polypeptides, methods and uses thereof
AU2017201090B2 (en) Nucleic acids and proteins from streptococcus groups A & B
AU1837100A (en) Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof
AU2017201090A1 (en) Nucleic acids and proteins from streptococcus groups A & B
AU5447999A (en) Novel protein and dna thereof
AU2381700A (en) Ndsp nucleic acids and polypeptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

17P Request for examination filed

Effective date: 20010227

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

XX Miscellaneous (additional remarks)

Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR.

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20050223

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050906